# Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors

> **NCT00114790** · PHASE1,PHASE2 · COMPLETED · sponsor: **Boneca Corporation** · enrollment: 30 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **RADIATION:** boronophenylalanine-based BNCT

## Key facts

- **NCT ID:** NCT00114790
- **Lead sponsor:** Boneca Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2008-10
- **Final completion:** 2012-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114790, "Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00114790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*